Recent Updates
Recently added Catalysts
CLNN Positive Sentiment

Clene to Present at the 36th Annual ROTH Conference

Thursday, March 7, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Clene Inc. will present at the upcoming 36th Annual ROTH Conference scheduled for March 18-19, 2024, in Dana Point, California. Clene, a clinical-stage biopharmaceutical company focused on treatments for neurodegenerative diseases, will participate in a fireside chat format at 8:00 a.m. PST. Webcast access will be available for those interested in viewing the presentation through Clene's website.
Price reaction · baseline $7.9 (2024-03-06 close) · hit after-hours · clean, no other CLNN news in the window
day 0 close
+2.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Clene is participating in a notable conference, increasing visibility.
  • The presentation may attract interest in Clene's novel therapies for neurodegenerative diseases.
  • Engaging in a fireside chat format adds a personal touch to their presentation.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+63%
120-day peak, hindsight
Typical move
5.3%
average across 6 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
CNMAu8
Phase 2 · Amyotrophic Lateral Sclerosis

Full Press Release Details

SALT LAKE CITY, March 07, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that it will participate in the 36th Annual ROTH Conference being held March 18-19, 2024.
Date: March 18, 2024
Location: The Ritz Carlton Laguna Niguel in Dana Point, California
Time of Presentation: 8:00 a.m. PST
Format: Fireside chat
A webcast of the presentation will be available on the “Events” section of the Clene website. Alternatively, one can register online to view the webcast here: https://wsw.com/webcast/roth48/clene/1959711.

Frequently Asked Questions

What is the focus of Clene Inc.?

Clene Inc. focuses on enhancing mitochondrial health and neuronal function.

When will Clene participate in the ROTH Conference?

Clene will participate in the ROTH Conference on March 18-19, 2024.

Where is the 36th Annual ROTH Conference held?

The conference will be held at The Ritz Carlton Laguna Niguel, California.

What time will Clene's presentation occur?

Clene's presentation is scheduled for 8:00 a.m. PST.

How can I view Clene's presentation online?

You can view the presentation via the Clene website's Events section.

ShareAdd on Google
Tags: CLNN Viatris Investor Conferences Healthcare Clene Inc. ROTH Conference neurodegenerative diseases clinical-stage biopharmaceutical amyotrophic lateral sclerosis
Last updated: Mar 7, 2024

Biotech snapshot

Cash runway
$10M liquidity · $1M/mo burn
~11 mo
Medium dilution risk
Lead asset
CNMAu8Phase 2
Amyotrophic Lateral Sclerosis →

Catalyst track record

+63%
best trade around CLNN's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for CLNN.

See every catalyst's timing & PoA →